Kura Oncology Stock Quote KURA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

20.63

Bid

19.68

Ask

21.20

Volume

605,625

20.26 Day's Range 21.25

7.41 52 Week Range 24.17

Market Cap

1.569B

Previous Close

20.59

Open

20.55

Last Trade

20.74

Last Trade Time

Financial Volume

$ 12,407,207

VWAP

20.4866

Average Volume (3m)

923,935

Shares Outstanding

76,136,963

Dividend Yield

PE Ratio

-10.28

Earnings Per Share (EPS)

-2

Revenue

Net Profit

-152.63M

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.kuraoncology.com

Headquarters

Wilmington, Delaware, USA

Founded

2015

Kura Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KURA. The last closing price for Kura Oncology was $20.59. Over the last year, Kura Oncology shares have traded in a share price range of $ 7.41 to $ 24.17.

Kura Oncology currently has 76,136,963 shares outstanding. The market capitalization of Kura Oncology is $1.57 billion. Kura Oncology has a price to earnings ratio (PE ratio) of -10.28.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.43	7.44791666667	19.2	21.25	18.95	599753	20.04756029	CS
4	0.54	2.68790443006	20.09	21.25	16.79	831742	18.98984334	CS
12	0.14	0.683260126891	20.49	24.17	16.79	923935	20.64642406	CS
26	11.87	135.502283105	8.76	24.17	8.17	1233560	17.17192394	CS
52	10.38	101.268292683	10.25	24.17	7.41	996195	14.60469348	CS
156	-6.7	-24.5151847786	27.33	27.54	7.41	838273	15.1253257	CS
260	5.46	35.9920896506	15.17	43	6.34	710996	17.74513134	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	662.59k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.47M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M